NCT00435214View on ClinicalTrials.gov

Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer

CompletedOBSERVATIONAL
Enrollment

131,110

Participants

Timeline

Start Date

January 29, 2007

Primary Completion Date

April 1, 2020

Study Completion Date

April 30, 2020

Conditions
Cervical Neoplasia
Trial Locations (1)

94612

Kaiser Permanente Northern California, Oakland

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00435214 - Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer | Biotech Hunter | Biotech Hunter